Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies

Chimeric antigen receptor-T cells (CAR-Ts) are an exciting new cancer treatment modality exemplified by the recent regulatory approval of two CD19-targeted CAR-T therapies for certain B cell malignancies. However, this success in the hematological setting has yet to translate to a significant level...

Descripción completa

Detalles Bibliográficos
Autores principales: Springuel, Lorraine, Lonez, Caroline, Alexandre, Bertrand, Van Cutsem, Eric, Machiels, Jean-Pascal H., Van Den Eynde, Marc, Prenen, Hans, Hendlisz, Alain, Shaza, Leila, Carrasco, Javier, Canon, Jean-Luc, Opyrchal, Mateusz, Odunsi, Kunle, Rottey, Sylvie, Gilham, David E., Flament, Anne, Lehmann, Frédéric F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790340/
https://www.ncbi.nlm.nih.gov/pubmed/31363930
http://dx.doi.org/10.1007/s40259-019-00368-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790340/
https://www.ncbi.nlm.nih.gov/pubmed/31363930
http://dx.doi.org/10.1007/s40259-019-00368-z

Ejemplares similares